Satellos Bioscience Inc Com V.ICO

Primary Symbol: ICOTF

Healthcare Biotechnology

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...

GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > immune

<< Previous

Bullboard Posts

Next >>

Comment by SuperMoneyon Feb 16, 2019 7:18am

41 Views

Post# 29374610

RE:RE:RE:RE:immune

Alba, good comments about IMNP and I agree. Monday will be a very interesting day for IMNP. I would also like to see what will happen on trading for ICO. Good luck to all!

Alba1314 wrote:

sovy888 wrote:
what exactly is so great about IMNP going bankrupt dude??? I don't follow your logic, they owe us a sheat load of millions how are we gonna get paid if they declare bankruptcy??? as far as I'm concerned we could me near man!

Lets make this clear: IMNP doesn't owe us anything! The agreement ICO has with IMNP is for royalty payments on retail sales IF the iCO008 goes to market. The drug is still in trials and not approved for treatment...SO NO RETAIL SALES!! Even if the drug were to be suucessful, those royalties would still be a few years away

If IMNP goes bankrupt, this means that iCo 008 and all it's data is free for iCo to license out to someone else...or if sufficient funding is received, iCo can continue the trials themselves with someone else having half the work. IF the drug proves successful, iCo would get more than the 25M in royalties this way. IMNP is dead weight to iCo.